0173-0846 : Tafinlar 50 mg Oral Capsule


NDC: 0173-0846
Labeler: Glaxosmithkline LLC
Product Type: Human Prescription Drug
Drug Name:  Tafinlar
Dosage Form: Oral Capsule
Application #: NDA202806
Rev. Date: 


Appearance:


Markings: GSTEW;50mg
Shapes:  Oval
Colors:  Red
Size (mm): 18
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0173-0846-08: 120 CAPSULE IN 1 BOTTLE (0173‑0846‑08)

Active Ingredients:

  • Dabrafenib Mesylate

Dosage Strength:

  • 50 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Hypromelloses
  • Ferric Oxide Red
  • Titanium Dioxide

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Cytochrome P450 2B6 Inducers [MoA]
  • Cytochrome P450 2C8 Inducers [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 2C19 Inducers [MoA]
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
  • Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
  • Organic Anion Transporter 1 Inhibitors [MoA]
  • Organic Anion Transporter 3 Inhibitors [MoA]
  • Breast Cancer Resistance Protein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0173-0847 Tafinlar 75 mg Oral Capsule by Glaxosmithkline LLC
  • 0078-0681 Tafinlar 75 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-0682 Tafinlar 50 mg Oral Capsule by Novartis Pharmaceuticals Corporation
  • 0078-1154 Tafinlar 10 mg Oral Tablet, for Suspension by Novartis Pharmaceuticals Corporation
  • 53873-023 Dabrafenib Mesylate by Glaxosmithkline Inc
  • 53873-024 Dabrafenib Mesylate by Glaxosmithkline Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0173-0846 QR Code

< Prev: 0173-0845Next: 0173-0847 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.